S100P and neoplasm: High S100P expression reduced the infiltration of macrophages and CD4 + T cells, thereby promoting tumor immune escape, and decreased the expression of common immune inhibitors, suggesting that S100P inhibition may improve the expression of treatment targets to improve the efficacy of immunotherapy.